Home
>
US Stocks
>
Celldex Therapeutics Inc.
Celldex Therapeutics Inc.
CLDX

Celldex Therapeutics Inc. (CLDX)

$46.930.97%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$47.64
Today Low/High
$46.16 / $48.06
52 Week Low/High
$14.56 / $57.2
P/E ratio
-33.3577
Market Cap
$2.2B

Company Details

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Organisation
Celldex Therapeutics Inc.
Headquaters
Hampton, New Jersey, US
Employees
124
Industry
Health Technology
CEO
Anthony Marucci

Discover more

Frequently Asked Questions

What is Celldex Therapeutics Inc. (CLDX) share price today?

Can Indians buy Celldex Therapeutics Inc. (CLDX) shares?

How can I buy Celldex Therapeutics Inc. (CLDX) shares from India?

Can Fractional shares of Celldex Therapeutics Inc. (CLDX) be purchased?

What are the documents required to start investing in Celldex Therapeutics Inc. (CLDX) stocks?

We are a SEBI registered investement advisor